
Exentia Pharmaceuticals Private Limited
About Exentia Pharmaceuticals Private Limited
Data last updated:
Exentia Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52602TG2018PTC124306. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.75 Lakh. It is led by directors Lakshmi Eswar Mohamatam and Hemalatha Paisakka.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.2 Lakh. For the same year it recorded a net loss of ₹2,457 (net margin -0.2%) and EBITDA of ₹14,960 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Exentia Pharmaceuticals
Contact details
Exentia Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 41 II – F Sri Malani Colony Manovikas Nagar, Ferozguda Tadbund Secunderabad – 500009, Hyderabad, Telangana, India – 500009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Exentia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Exentia Pharmaceuticals Private Limited
FY 2023 filings availableExentia Pharmaceuticals Private Limited reported revenue of ₹10.2 Lakh for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years. EBITDA rose 250% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,960 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,457 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exentia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Exentia Pharmaceuticals Private Limited
Exentia Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmi Eswar Mohamatam | Director | 16 Aug 2023 | 3 Years 2 Months | Current |
| Hemalatha Paisakka Also directs: Hexafab Technologies Private Limited | Director | 30 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Exentia Pharmaceuticals Private Limited is audited by V NAGARAJU & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V NAGARAJU & CO | FY 2022 | 015578S |
Shareholding
The shareholding of Exentia Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Exentia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Exentia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exentia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Exentia Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Exentia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Exentia Pharmaceuticals Private Limited has 5 board changes on record since 2023: 2 appointments and 3 cessations. The latest: Lakshmi Eswar Mohamatam was appointed as Director on 16 Aug 2023.
Frequently asked questions
Exentia Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 May 2018 (8+ years old) and is registered under CIN U52602TG2018PTC124306.
Exentia Pharmaceuticals has 2 current directors:
- Lakshmi Eswar Mohamatam - Director
- Hemalatha Paisakka - Director
The latest financial statements of Exentia Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
No. Exentia Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Exentia Pharmaceuticals is U52602TG2018PTC124306. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exentia Pharmaceuticals was incorporated on 07 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lakshmi Eswar Mohamatam was appointed as Director on 16 Aug 2023. Nalinilakshmiprasanna Ghantasala ceased to be Director on 16 Aug 2023. Hemalatha Paisakka was appointed as Director on 30 Apr 2023. Exentia Pharmaceuticals has 5 board changes on record in total.
Yes, Exentia Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Exentia Pharmaceuticals is at Plot No. 41 II – F Sri Malani Colony Manovikas Nagar, Ferozguda Tadbund Secunderabad – 500009, Hyderabad, Telangana, India – 500009.
Exentia Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

